News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Horvath Susan
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/01/2020 |
4
| Horvath Susan (V.P. of Finance & CFO) has filed a Form 4 on Sun BioPharma, Inc.|
Txns:
| Bought 2,424 shares
@ $0
Bought 2,424 warrants
@ $4.54, valued at
$11k
|
|
| 06/26/2020 |
4
| Horvath Susan (V.P. of Finance & CFO) has filed a Form 4 on Sun BioPharma, Inc.|
Txns:
| Granted 32,000 options to buy
@ $4.98, valued at
$159.4k
|
|
| 06/09/2020 |
4
| Horvath Susan (V.P. of Finance & CFO) has filed a Form 4 on Sun BioPharma, Inc.|
Txns:
| Bought 2,500 shares
@ $0
Bought 2,500 warrants
@ $6, valued at
$15k
|
|
| 09/26/2019 |
4
| Horvath Susan (V.P. of Finance & CFO) has filed a Form 4 on Sun BioPharma, Inc.|
Txns:
| Granted 25,000 options to buy
@ $5, valued at
$125k
|
|
| 09/04/2019 |
4
| Horvath Susan (V.P. of Finance & CFO) has filed a Form 4 on Sun BioPharma, Inc.|
Txns:
| Bought 1,428 shares
@ $0
Bought 1,428 warrants
@ $4, valued at
$5.7k
|
|
| 07/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/23/2019 |
4
| Horvath Susan (V.P. of Finance & CFO) has filed a Form 4 on Sun BioPharma, Inc.|
Txns:
| Granted 9,500 options to buy
@ $2.95, valued at
$28k
Granted 48,300 options to buy
@ $2.95, valued at
$142.5k
|
|
| 01/03/2019 |
4
| Horvath Susan (V.P. of Finance & CFO) has filed a Form 4 on Sun BioPharma, Inc.|
Txns:
| Bought 23,625 convertible notes
@ $0
Bought 13,500 warrants
@ $4.5, valued at
$60.8k
|
|
| 04/19/2018 |
4
| Horvath Susan (V.P. of Finance & CFO) has filed a Form 4 on Sun BioPharma, Inc.|
Txns:
| Granted 40,000 options to buy
@ $5.75, valued at
$230k
|
|
| 04/19/2018 |
3
| Horvath Susan (V.P. of Finance & CFO) has filed a Form 3 on Sun BioPharma, Inc. |
|
|